Homocystinuria: Clinical Trials

6 trials for Homocystinuria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 suspended, 1 terminated. 6 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Recruiting 1, Suspended 1, Terminated 1
Phase 14Completed 1, Recruiting 1, Suspended 1, Terminated 1

Follow Homocystinuria: new trials by email Literature Review of Homocystinuria trials Research Report on Homocystinuria

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on Homocystinuria
Acetaminophen, N-acetylcysteine - CBS Deficiency
Phase 1 / Phase 2SuspendedHospital de Clinicas de Porto Alegre102022-02-112021-06-30
A Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency
Pegtarviliase IV, Pegtarviliase SC - Homocystinuria Due to Cystathionine Beta-Synthase Deficiency
Phase 1 / Phase 2TerminatedAeglea Biotherapeutics132021-05-132023-07-27
Pegtibatinase as a Treatment for Patients With Classical Homocystinuria (HCU) (Also Known as the COMPOSE Study)
Pegtibatinase, Placebo - Homocystinuria
Phase 1 / Phase 2RecruitingTravere Therapeutics, Inc.392019-01-222026-08-10
Betaine METABOLISM OF PATIENTS With Homocystinuria
Betaine - Homocystinuria
Phase 2CompletedAssistance Publique - Hôpitaux de Paris122015-07-012023-02-03
Oxidative Stress Markers In Inherited Homocystinuria And The Impact Of Taurine
taurine - Homocystinuria
Phase 1 / Phase 2CompletedUniversity of Colorado, Denver152010-01-012018-07-09
Homocystinuria: Treatment With N-Acetylcysteine
N-acetylcysteine - Homocystinuria
Phase 2CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre52007-11-012009-02-18

Broader conditions

Amino Acid Metabolism, Inborn Errors (6)  ·  Brain Diseases (6)  ·  Brain Diseases, Metabolic (6)  ·  Brain Diseases, Metabolic, Inborn (6)  ·  Central Nervous System Diseases (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Connective Tissue Diseases (6)  ·  Genetic Diseases, Inborn (6)  ·  Hyperhomocysteinemia (6)  ·  Metabolic Diseases (6)  ·  Metabolism, Inborn Errors (6)  ·  Nervous System Diseases (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Skin and Connective Tissue Diseases (6)

Interventions

Acetylcysteine (2)  ·  Acetaminophen (1)  ·  Betaine (1)  ·  Taurine (1)

Sponsors

Aeglea Biotherapeutics (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Travere Therapeutics, Inc. (1)  ·  University of Colorado, Denver (1)

Countries

United States (3)  ·  France (2)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  Qatar (1)  ·  United Kingdom (1)

Top investigators

Cortney Caudill (1)  ·  Ida VD Schwartz, PhD (1)  ·  Johan VanHove, MD PhD MBA (1)  ·  Michael Imperiale, MD (1)

Results publications

PMID 36376887, PMID 40382700

NIH funding

2019 (1)